Laninamivir
- Generic Name
- Laninamivir
- Drug Type
- Small Molecule
- Chemical Formula
- C13H22N4O7
- CAS Number
- 203120-17-6
- Unique Ingredient Identifier
- B408IW3GL5
- Background
Laninamivir has been used in trials studying the treatment of Influenza.
- Indication
用于儿童和成人流感病毒感染的治疗和预防。
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
- Conditions
- InfluenzaInfluenza, Human
- Interventions
- First Posted Date
- 2022-12-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 3000
- Registration Number
- NCT05648448
- Locations
- 🇧🇷
Universidade Federal de Minas Gerais, Minas Gerais, Brazil
🇱🇦Laos-Oxford-Mahosot Wellcome Trust Research unit, Vientiane, Lao People's Democratic Republic
🇳🇵Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, Nepal
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT02014649
- Locations
- 🇺🇸
Precision Trials LLC, Phoenix, Arizona, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Dayton Children's Hospital, Dayton, Ohio, United States
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2018-05-31
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 639
- Registration Number
- NCT01793883
- Locations
- 🇺🇸
Clinical Research Solutions, PC, Smyrna, Tennessee, United States
🇺🇸BRCR Medical Center, Inc DBA Boca Raton Clinical Research, Boca Raton, Florida, United States
🇺🇸Clinical Research Connections, LLC, Harrisburg, Arkansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.